Campbell & Co Investment Adviser’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-128,309
Closed -$769K – 1267
2026
Q1
$769K Buy
128,309
+16,916
+15% +$127K 0.04% 596
2025
Q4
$799K Buy
111,393
+41,735
+60% +$330K 0.04% 654
2025
Q3
$744K Sell
69,658
-7,533
-10% -$73.9K 0.06% 549
2025
Q2
$747K Buy
+77,191
New +$796K 0.05% 630

Other funds holding OGN

Campbell & Co Investment Adviser's OGN Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 128,309 shares — an estimated $769K sold.

Campbell & Co Investment Adviser first reported a position in OGN in Q2 2025 and held it in 4 quarters. The position peaked at $799K in Q4 2025. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 128,309 Organon & Co shares in Q2 2026, an estimated $769K.
  • Campbell & Co Investment Adviser first reported a position in Organon & Co in Q2 2025 and held it in 4 quarters.
  • Campbell & Co Investment Adviser's Organon & Co position peaked at $799K in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.